Literature DB >> 23255763

Can CT features differentiate between inferior vena cava leiomyosarcomas and primary retroperitoneal masses?

Emily M Webb1, Zhen J Wang, Antonio C Westphalen, Eric K Nakakura, Fergus V Coakley, Benjamin M Yeh.   

Abstract

OBJECTIVE: The objective of our study was to evaluate and describe CT features that may differentiate inferior vena cava (IVC) leiomyosarcomas from primary retroperitoneal masses.
MATERIALS AND METHODS: A records search revealed 18 CT examinations with a soft-tissue mass contacting the IVC. Three readers evaluated the scans for four signs: an imperceptible IVC at the interface with the mass; a "positive embedded organ" sign (IVC embedded in the periphery of the mass); a "negative embedded organ" sign (IVC compressed at the perimeter of the mass); and tumor in the IVC lumen. CT findings were compared with pathology and operative reports. Performance and significance of CT features and interobserver agreement were calculated.
RESULTS: Four of 18 (22%) retroperitoneal masses were IVC leiomyosarcomas. The IVC was imperceptible at the interface with the mass in three of the four (75%) IVC leiomyosarcomas (κ = 0.88) and in no alternate diagnosis (p < 0.02). No IVC leiomyosarcoma showed a positive embedded organ sign versus one of 14 masses of alternate origin (p = 1.0, κ = 0.56). The negative embedded organ sign was seen in most primary retroperitoneal masses (11/14 or 79%, κ = 0.85) but in no case of IVC leiomyosarcoma (p = 0.01). Intraluminal tumor was seen in one of four (25%) IVC leiomyosarcomas and in two of 14 other retroperitoneal masses (p = 1.0, κ = 1.0).
CONCLUSION: An imperceptible IVC at the point of maximal contact with a retroperitoneal mass was the most useful CT feature for predicting the origin of IVC leiomyosarcoma. A negative embedded organ sign was useful for excluding IVC origin. Knowledge of these CT features may assist with preoperative planning.

Entities:  

Mesh:

Year:  2013        PMID: 23255763     DOI: 10.2214/AJR.11.7476

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

1.  Leiomyosarcoma of the inferior vena cava: a case report.

Authors:  Rafael Lemos Nascif; Ana Graziela Santana Antón; Gabriel Lacerda Fernandes; George Caldas Dantas; Vinícius de Araújo Gomes; Marcelo Ricardo Canuto Natal
Journal:  Radiol Bras       Date:  2014 Nov-Dec

2.  Treatment of a Double Cancer Patient With Primary Inferior Vena Cava Sarcoma and Lung Adenocarcinoma: A Case Report and Literature Review.

Authors:  Xiaohu Guo; Zhengang Wei; Mancai Wang; Youcheng Zhang
Journal:  Front Surg       Date:  2022-04-06

3.  Primary Leiomyosarcoma in the Inferior Vena Cava Extended to the Right Atrium: A Case Report and Review of the Literature.

Authors:  Shuichi Fujita; Hideaki Takahashi; Yumiko Kanzaki; Tomohiro Fujisaka; Yoshihiro Takeda; Hideki Ozawa; Hiroko Kuwabara; Takahiro Katsumata; Nobukazu Ishizaka
Journal:  Case Rep Oncol       Date:  2016-10-12

Review 4.  Current Concepts in Non-Gastrointestinal Stromal Tumor Soft Tissue Sarcomas: A Primer for Radiologists.

Authors:  Akshay D Baheti; Jyothi P Jagannathan; Ailbhe O'Neill; Harika Tirumani; Sree Harsha Tirumani
Journal:  Korean J Radiol       Date:  2017-01-05       Impact factor: 3.500

5.  Heterotopic Ossification of the Inferior Vena Cava Wall: A Case Report and Literature Review.

Authors:  Jihua Tian; Li Zhang; Min Hu; Xing Zeng; Yongjun Wang; Chunguang Yang; Zhiquan Hu
Journal:  Front Surg       Date:  2021-12-02

Review 6.  Leiomyosarcoma of the inferior vena cava. Our experience and a review of the literature.

Authors:  Cristian Bogdan Rusu; Lilian Gorbatâi; Ludovic Szatmari; Rumelia Koren; Cătălina Ileana Bungărdean; Bogdan Ovidiu Feciche; Călin Bumbuluţ; Iulia Mădălina Andraş; Răzvan Rahotă; Teodora Telecan; Ioan Coman; Lea Rath-Wolfson; Nicolae Crişan
Journal:  Rom J Morphol Embryol       Date:  2020       Impact factor: 1.033

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.